Inspire Medical Systems Past Earnings Performance
Past criteria checks 3/6
Inspire Medical Systems has been growing earnings at an average annual rate of 22.2%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 44.4% per year. Inspire Medical Systems's return on equity is 4.7%, and it has net margins of 4.4%.
Key information
22.2%
Earnings growth rate
24.9%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 44.4% |
| Return on equity | 4.7% |
| Net Margin | 4.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Getting In Cheap On Inspire Medical Systems, Inc. (NYSE:INSP) Might Be Difficult
Dec 11
Inspire Medical Systems: Getting Cheaper But Not There Yet
Nov 23Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems: Time To Wake Up
Nov 17Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15Revenue & Expenses Breakdown
How Inspire Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 756 | 33 | 512 | 115 |
| 30 Jun 24 | 706 | 6 | 495 | 118 |
| 31 Mar 24 | 661 | -16 | 476 | 120 |
| 31 Dec 23 | 625 | -21 | 452 | 117 |
| 30 Sep 23 | 570 | -33 | 423 | 107 |
| 30 Jun 23 | 526 | -41 | 395 | 99 |
| 31 Mar 23 | 466 | -44 | 359 | 82 |
| 31 Dec 22 | 408 | -45 | 321 | 69 |
| 30 Sep 22 | 348 | -50 | 285 | 58 |
| 30 Jun 22 | 301 | -44 | 252 | 46 |
| 31 Mar 22 | 262 | -43 | 224 | 41 |
| 31 Dec 21 | 233 | -42 | 203 | 37 |
| 30 Sep 21 | 201 | -47 | 182 | 34 |
| 30 Jun 21 | 175 | -47 | 162 | 32 |
| 31 Mar 21 | 134 | -57 | 141 | 29 |
| 31 Dec 20 | 115 | -57 | 128 | 26 |
| 30 Sep 20 | 96 | -59 | 117 | 23 |
| 30 Jun 20 | 81 | -57 | 107 | 19 |
| 31 Mar 20 | 87 | -41 | 100 | 16 |
| 31 Dec 19 | 82 | -33 | 90 | 13 |
| 30 Sep 19 | 72 | -29 | 78 | 11 |
| 30 Jun 19 | 64 | -25 | 69 | 9 |
| 31 Mar 19 | 57 | -24 | 62 | 8 |
| 31 Dec 18 | 51 | -22 | 54 | 7 |
| 30 Sep 18 | 44 | -21 | 48 | 7 |
| 30 Jun 18 | 38 | -21 | 42 | 6 |
| 31 Mar 18 | 33 | -20 | 37 | 6 |
| 31 Dec 17 | 29 | -18 | 32 | 6 |
| 31 Dec 16 | 16 | -19 | 23 | 7 |
| 31 Dec 15 | 8 | -21 | 18 | 7 |
Quality Earnings: INSP has high quality earnings.
Growing Profit Margin: INSP became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INSP has become profitable over the past 5 years, growing earnings by 22.2% per year.
Accelerating Growth: INSP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: INSP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).
Return on Equity
High ROE: INSP's Return on Equity (4.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 03:36 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inspire Medical Systems, Inc. is covered by 24 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| David Rescott | Baird |
| Ravi Misra | Berenberg |